Christie M. Ballantyne, MD
Advertisement
Articles by Christie M. Ballantyne, MD
Advertisement
Latest Updated Articles
- Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Management
Published: May 1st 2001 | Updated:
- Safety and Tolerability of Lipid-Lowering Drugs After Heart Transplantation: The Heart Transplant Lipid Registry
Published: March 1st 1997 | Updated:
- Treating Hyperlipidemia to Prevent Coronary Heart Disease: What Are the Treatment Goals and How Do We Get There?
Published: September 1st 1997 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Fixed-Duration Epcoritamab Plus Chemotherapy Yields Response, Remissions in DLBCL
2
EPCORE FL-1: Adding Epcoritamab to R2 Delivers “New Benchmark” in Second-Line Follicular Lymphoma
3
ASH 2025 Offers Data That Could Make Novel Therapies More Accessible
4
In CLL, Fixed-Duration Venetoclax Combos Are Equal to Continuous Ibrutinib in Head-to-Head Comparison
5
